Vision Marine Technologies Accelerates Operational Transformation with NVG Segment Near EBITDA Breakeven and Significant Balance Sheet Improvements
NervGen Pharma Announces Successful End-of-Phase 2 Meeting and FDA Alignment on RESTORE, a Phase 3 Registrational Study of NVG-291 for Chronic Tetraplegia
RiverNorth Capital Trims Position in Nuveen AMT-Free Municipal Credit Income Fund
NVG Vs. NZF: Comparing Nuveen Munis I Hold
Nuveen AMT-Free Municipal Credit Income Fund (NYSE:NVG) Stock Price Crosses Above Fifty Day Moving Average – Here’s Why
NervGen Pharma Reports Third Quarter Financial Results and Provides Business Updates
NVG: Tax Efficiency And High Yield In Municipal Bonds
NervGen Pharma's NVG-291-R Demonstrates Significant Functional Recovery in Department of Defense-Sponsored Preclinical Models of Traumatic Hearing Loss and Peripheral Nerve Injury
NervGen Announces Clinical Leadership Transition as NVG-291 Continues to Advance Toward Late-Stage Development and Regulatory Milestones
NervGen Pharma: Risky, Yet Promising With Big Upside
NVG: Converting Capital Into Income
NervGen Pharma to Present Topline Data for NVG-291 Phase 1b/2a Chronic Cohort Study at the American Spinal Injury Association Annual Scientific Meeting
NervGen Pharma Reports 2024 Year-End Financial Results and Provides Business Updates
NervGen Pharma to Host Virtual Investor Event
NervGen Completes Dosing of First Subject in Subacute Cohort of its Phase 1b/2a Clinical Trial of NVG-291 in Spinal Cord Injury
NervGen Completes Enrollment in Chronic Cohort of its Phase 1b/2a Clinical Trial of NVG-291 in Spinal Cord Injury
NVG: Distribution Increase Leads To Expected Discount Narrowing
NervGen Pharma Provides Update on Phase 1b/2a Clinical Trial of NVG-291 in Spinal Cord Injury
NVG: Muni Fund To Buy Hand Over Fist
NervGen Pharma to Advance NVG-300 into Preclinical Proof-of-Concept Stage
XMPT: Muni Bond CEFs Looking More Appealing
NVG: 3 Reasons To Be Cautious Despite Large Discount To NAV
Nuveen Closed-End Funds Declare Distributions and Updates to Distribution Policies
NVG: Historic Discount Available Keeps My Buy Rating
Board Announces Removal of Merger Proposal from Annual Meeting Agenda
Weekly Closed-End Fund Roundup: DEX Will Merge With AGD, Tender Next January (December 11, 2022)
NVG: Nuveen's Best AMT-Free Muni Bond CEF
Muni Bond CEFs: PIMCO Or Nuveen? The Choice Is Obvious In This Market Environment
Will Bankruptcy Era Prices Finally Stop The Bleeding In Municipal Bond CEFs?
Muni CEFs: Back Up The Truck On NVG And NZF
Nuveen AMT-Free Municipal Credit Income Fund Is A Good Choice For That Strategy
Nuveen Credit-Focused Muni CEFs Remain Attractive
NVG: Nuveen's Higher Yielding AMT-FREE Municipal Bond CEF
Certain Nuveen Closed-End Funds Announce the Board’s Approval of Amended and Restated By-Laws of the Funds
Treasury Curve Bear-Steepened; Muni Yields Higher - Muni Fortnightly, August 31, 2020
Treasuries Had A Bear-Steepening Week: Fixed Income Weekly Monitor, August 31, 2020
Rule #1 For Bonds: Don't Lose Money
For Muni Investors, COVID-19 Provides Lessons In Liquidity
Small Ways Muni Investors Can Make A Big Difference
What Happened In The Bond Markets Last Week? Muni Fortnightly, July 20, 2020
Parallel Advisors LLC Decreases Holdings in Nuveen AMT-Free Municipal Credit Income (NYSE:NVG)
2020 Muni Market Midyear Update
Nuveen AMT-Free Municipal Credit Income (NYSE:NVG) to Issue Monthly Dividend of $0.07
Income Lab Ideas: Best Fund Sponsors For Each Sector
Heroes And Villains
The Muni Selloff That Was
Responsible Investing In A Traditional Asset Class
The Reopening Killed The V-Shaped Recovery
Treasury Yields Were Little Changed In Low Volatility - Muni Fortnightly, June 22, 2020
Nuveen AMT-Free Municipal Credit Income (NYSE:NVG) Shares Sold by Baird Financial Group Inc.